Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis-Reference-Cited by-同舟云学术

Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis

Published:2017-02 Issue:2 Volume:1863 Page:450-461
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Roversi Fernanda Marconi,Pericole Fernando Vieira,Machado-Neto João Agostinho,da Silva Santos Duarte Adriana,Longhini Ana Leda,Corrocher Flávia Adolfo,Palodetto Bruna,Ferro Karla Priscila,Rosa Renata Giardini,Baratti Mariana Ozello,Verjovski-Almeida Sergio,Traina Fabiola,Molinari Alessio,Botta Maurizio,Saad Sara Teresinha Olalla

Funder

CNPq

FAPESP

INCT-Sangue

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference45 articles.

1. Pharmacogenetics, pharmacogenomics, and individualized medicine;Ma;Pharmacol. Rev.,2011

2. Regulation of SRC family kinases in human cancers;Sen;J. Signal Transduct.,2011

3. Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia;Hoshino;Leukemia,2007